Profilo
Attualmente, Samina Khan ricopre la posizione di Chief Medical Officer e Senior Vice President di Reata Pharmaceuticals, Inc. La dottoressa Khan è stata in precedenza vicepresidente dei programmi cardio-renali alla Quark Pharmaceuticals, Inc.
Precedenti posizioni note di Samina Khan
| Società | Posizione | Fine |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 26/09/2023 |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Corporate Officer/Principal | 01/04/2017 |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di Samina Khan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















